A Phase 1 study of Olomorasib in hepatic impairment

Completed Phase 1 NCT06719128

Study Description

A study to evaluate how the liver processes the drug Olomorasib in people with different levels of liver function

Study Details

Registry ID:
NCT06719128
Conditions:
Hepatic Insufficiency, Healthy
Phase:
Phase 1
Target Enrollment:
46 participants
Start Date:
Age Range:
18–75 years
Healthy Volunteers:
No

Study Locations (4 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →